Industry News: Microbiome Connect: Europe returns in July 2023
Join industry leaders across Europe in therapeutic drug development to share insights, drive investment, and build new partnerships
The landscape of microbiome drug development is constantly evolving. The road to market is incredibly complex and it is vital to find the right strategic partners to bring products to patients. Join fellow microbiology researchers at Microbiome Connect: Europe in Amsterdam, Netherlands on July 5-6, 2023 to discover new innovative technologies and the latest microbiome drug developments.
Bringing together the whole microbiome therapeutics ecosystem – from investors and large pharmaceutical companies to the most pioneering biotechs, academic institutions, and solution providers – Microbiome Connect: Europe will deliver business-critical information through in-depth case studies and will offer expanded networking opportunities.
Featured speakers include:
- Karine Roget, CSO, Nexbiome Tx
- Denise Kelly, Investment Advisor, Seventure Partners
- Yuri Martina, CMO, Destiny Pharma
- Nathalie Corvaia, CSO, MaaT Pharma
- Chrysi Sergaki, Principal Investigator, MHRA
Register your place and download the agenda here >>
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
_(1).gif)
.gif)
Related Articles
- Achieve accuracy and reliability in cell counting
- Optimize drug development with advanced bioanalysis
- Bioanalytic breakthroughs redefine drug development
- Analytical measurements supporting cellular therapies
- Kuraray launches new PVA hydrogel microcarriers for cell cultures
- Evolution in gene therapy vector analysis